Recare Secures €37M Growth Funding Led by DNV

Why It Matters

The funding fuels rapid scaling of AI‑enabled care coordination, addressing acute staffing shortages and positioning Recare as a key player in Europe’s digital health transformation.

Key Takeaways

• €37M round led by DNV, includes €7M option.
• DNV becomes Recare's largest shareholder.
• Funds target AI agent rollout and international expansion.
• AI hub automates discharge, documentation, data extraction.
• Addresses staff shortages via workflow automation.

Pulse Analysis

Recare’s €37 million financing reflects a growing investor appetite for AI‑powered health‑care solutions in Europe. Led by DNV, a firm known for risk‑management expertise, the round underscores confidence in Recare’s ability to modernize hospital workflows. The involvement of CIBC Innovation Banking adds a North‑American perspective, hinting at potential cross‑border partnerships that could accelerate market penetration beyond Germany. By securing the largest shareholder position, DNV not only provides capital but also strategic oversight, aligning compliance standards with Recare’s rapid product development.

At the core of Recare’s growth is its AI agent, a smart hub that integrates with existing hospital information systems to streamline discharge processes. The technology automatically extracts data from PDFs, scans, and free‑text notes, converting them into interoperable formats that feed directly into clinical and administrative workflows. This automation reduces manual documentation time, cuts errors, and frees clinicians to focus on patient care—critical advantages amid Europe’s widening healthcare staffing gaps. Early adopters report faster hand‑over protocols and improved coordination across departments, validating the platform’s value proposition.

Looking ahead, the new capital positions Recare to scale its solution across multiple European markets and potentially enter the U.S. landscape. International expansion will require localization of data‑privacy compliance and integration with diverse health‑IT ecosystems, challenges that DNV’s risk‑management background can help mitigate. As hospitals increasingly prioritize digital transformation, Recare’s AI‑driven discharge platform could set a benchmark for end‑to‑end care coordination, prompting competitors to accelerate their own automation roadmaps. The funding round thus not only fuels Recare’s growth but also signals a broader shift toward AI‑centric operational efficiency in the healthcare sector.

Deal Summary

Berlin‑based health‑tech firm Recare announced the close of a growth financing round of up to €37 million, including a €7 million option. The round was led by DNV with participation from CIBC Innovation Banking and other investors, making DNV the largest shareholder. The capital will fund international expansion, development of a new AI agent, and further growth of its SaaS platform for hospitals.